XM无法为美国居民提供服务。
P
P

Patterson-UTI

交易方向

交易者偏好

技术摘要

每小时

市场新闻

U.S. Aadi Bioscience, Target, Visteon

U.S. RESEARCH ROUNDUP-Aadi Bioscience, Target, Visteon Aug 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aadi Bioscience, Target and Visteon, on Thursday. HIGHLIGHTS * Aadi Bioscience Inc AADI.O : Jefferies cuts to hold from buy * Assurant Inc AIZ.N : Piper Sandler cuts to neutral from overweight * Estée Lauder EL.N : Piper Sandler raises to overweight from neutral * Target Corp TGT.N : Jefferies raises target
A
A
H
S
T
T
U
A
P
U
D
E
A

Patterson-UTI Energy Inc reports results for the quarter ended in June - Earnings Summary

Patterson-UTI Energy Inc reports results for the quarter ended in June - Earnings Summary Patterson-UTI Energy Inc PTEN.OQ reported quarterly adjusted earnings of 3 cents​​ per share for the quarter ended in June, lower than the same quarter last year, when the company reported EPS of 45 cents. The mean expectation of nineteen analysts for the quarter was for earnings of 9 cents per share.
P

Patterson-UTI Energy Q2 Revenue USD 1,300 Million Vs. IBES Estimate USD 1,419 Million

BRIEF-Patterson-UTI Energy Q2 Revenue USD 1,300 Million Vs. IBES Estimate USD 1,419 Million Jul 25 (Reuters) - Patterson-UTI Energy Q2 net income USD 11 million. Q2 EPS USD 0.03 vs. IBES estimate USD 0.09 Q2 dividend USD 0.08
P

Patterson-UTI Energy Inc <PTEN.OQ> expected to post earnings of 9 cents a share - Earnings Preview

Patterson-UTI Energy Inc expected to post earnings of 9 cents a share - Earnings Preview Patterson-UTI Energy Inc PTEN.OQ PTEN.O is expected to show a rise in quarterly revenue when it reports results on July 25 for the period ending June 30 2024 The Houston Texas-based company is expected to report a 87.0% increase in revenue to $1.419 billion from $758.89 million a year ago, according to the mean estimate from 15 analysts, based on LSEG data.
P

U.S. Armada Hoffler Properties, Morphic Holding, Solid Biosciences

U.S. RESEARCH ROUNDUP-Armada Hoffler Properties, Morphic Holding, Solid Biosciences July 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Armada Hoffler Properties, Morphic Holding and Solid Biosciences, on Monday. HIGHLIGHTS * Armada Hoffler Properties Inc AHH.N : Jefferies cuts to hold from buy * Morphic Holding Inc MORF.O : Jefferies cuts to hold from buy * Solid Biosciences Inc SLDB.O : JP Morgan raises to over
A
A
C
C
H
J
A
E
P
U
W
A
E
H
M

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明